Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

View:
Post by Roller007 on May 06, 2016 2:23pm

Endo example

So if there isn't a buyout and the earnings miss or guidance I spoke then Cxr will plummet to $18 by Endo's example.  Interesting zero tolerance by the markets.  I'm still saying this will be gone soon
Comment by CNInvesting on May 06, 2016 2:35pm
Yeah long live the lemmings.
Comment by StevieCohen on May 06, 2016 2:36pm
Unless we all of a sudden live in a communist country, the government can't force drug companies of generic drugs to cut their prices.  Don't want the drug, go buy it somewhere else, not made by someone else you say?  Well then there's a fuucking reason someone else isn't making it.  It a free fuucking market and people act like concordia is running a monopolistic ...more  
Comment by fdfd12 on May 06, 2016 2:43pm
Well said Stevie.
Comment by merts01 on May 06, 2016 2:52pm
Best post of the day Stevie.  Thank you. 
Comment by select1011 on May 06, 2016 3:05pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities